Skip to content
10-Q

Quarterly Report

Allogene Therapeutics, Inc. ALLO

0001737287-25-000088

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 221.88M sh
Shares Diluted Q2 2025 · Jun 30, 2025 218.93M sh
Shares Diluted Q2 2025 · Jun 30, 2025 217.15M sh
Shares Diluted Q2 2025 · Jun 30, 2024 190.03M sh
Shares Diluted Q2 2025 · Jun 30, 2024 179.58M sh
Capex Q2 2025 · Jun 30, 2025 $143K
Capex Q2 2025 · Jun 30, 2024 $8K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$91.96M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$119.49M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $52.33M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $75.22M
Stockholders Equity Q2 2025 · Jun 30, 2025 $344.56M
Stockholders Equity Q2 2025 · Mar 31, 2025 $385.39M
Stockholders Equity Q2 2025 · Dec 31, 2024 $422.18M
Stockholders Equity Q2 2025 · Jun 30, 2024 $515.04M
Stockholders Equity Q2 2025 · Mar 31, 2024 $461.37M
Stockholders Equity Q2 2025 · Dec 31, 2023 $512.23M
Current Liabilities Q2 2025 · Jun 30, 2025 $31.68M
Current Liabilities Q2 2025 · Dec 31, 2024 $35.52M
Total Liabilities Q2 2025 · Jun 30, 2025 $126.03M
Total Liabilities Q2 2025 · Dec 31, 2024 $126.53M
Current Assets Q2 2025 · Jun 30, 2025 $282.66M
Current Assets Q2 2025 · Dec 31, 2024 $303.39M
Total Assets Q2 2025 · Jun 30, 2025 $470.59M
Total Assets Q2 2025 · Dec 31, 2024 $548.71M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.23
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.51
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.35
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.73
Eps Basic Q2 2025 · Jun 30, 2025 −$0.23
Eps Basic Q2 2025 · Jun 30, 2025 −$0.51
Eps Basic Q2 2025 · Jun 30, 2024 −$0.35
Eps Basic Q2 2025 · Jun 30, 2024 −$0.73
Sga Expense Q2 2025 · Jun 30, 2025 $14.28M
Sga Expense Q2 2025 · Jun 30, 2025 $29.27M
Sga Expense Q2 2025 · Jun 30, 2024 $16.09M
Sga Expense Q2 2025 · Jun 30, 2024 $33.35M
Rd Expense Q2 2025 · Jun 30, 2025 $40.16M
Rd Expense Q2 2025 · Jun 30, 2025 $90.36M
Rd Expense Q2 2025 · Jun 30, 2024 $50.36M
Rd Expense Q2 2025 · Jun 30, 2024 $102.61M
Net Income Q2 2025 · Jun 30, 2025 −$50.94M
Net Income Q2 2025 · Jun 30, 2025 −$110.68M
Net Income Q2 2025 · Mar 31, 2025 −$59.73M
Net Income Q2 2025 · Jun 30, 2024 −$66.36M
Net Income Q2 2025 · Jun 30, 2024 −$131.36M
Net Income Q2 2025 · Mar 31, 2024 −$65M
Operating Income Q2 2025 · Jun 30, 2025 −$56.82M
Operating Income Q2 2025 · Jun 30, 2025 −$122.01M
Operating Income Q2 2025 · Jun 30, 2024 −$71.43M
Operating Income Q2 2025 · Jun 30, 2024 −$140.94M
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2025 $0
Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2024 $22K